David C. Sachs
CIK: 0001848899
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ImmunityBio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Feb 22, 2026IBRX
ImmunityBio, Inc.
Tax Payment(F)Direct20.7K shares at avg. $8.70$180K - Feb 22, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct40.7K shares- - Feb 10, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct82.2K shares- - Feb 10, 2026IBRX
ImmunityBio, Inc.
Tax Payment(F)Direct42.6K shares at avg. $6.93$296K - Dec 31, 2025IBRX
ImmunityBio, Inc.
Exercise(M)Direct30.4K shares- - Dec 31, 2025IBRX
ImmunityBio, Inc.
Tax Payment(F)Direct15.4K shares at avg. $1.98$31K - Feb 22, 2025IBRX
ImmunityBio, Inc.
Tax Payment(F)Direct15.9K shares at avg. $3.42$54K - Feb 22, 2025IBRX
ImmunityBio, Inc.
Exercise(M)Direct40.7K shares- - Feb 10, 2025IBRX
ImmunityBio, Inc.
Award(A)DirectRestricted Stock Units
246.7K shares- - Feb 10, 2025IBRX
ImmunityBio, Inc.
Award(A)DirectStock Option (right to buy)
843.8K shares- - Dec 31, 2024IBRX
ImmunityBio, Inc.
Exercise(M)Direct30.4K shares- - Dec 31, 2024IBRX
ImmunityBio, Inc.
Tax Payment(F)Direct15.4K shares at avg. $2.56$39K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 22, 2026 | IBRX ImmunityBio, Inc. | Tax Payment(F) | 20,682 | $8.70 | $179,933 | Direct |
| Feb 22, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 40,650 | - | $0 | Direct |
| Feb 10, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 82,236 | - | $0 | Direct |
| Feb 10, 2026 | IBRX ImmunityBio, Inc. | Tax Payment(F) | 42,643 | $6.93 | $295,516 | Direct |
| Dec 31, 2025 | IBRX ImmunityBio, Inc. | Exercise(M) | 30,397 | - | $0 | Direct |
| Dec 31, 2025 | IBRX ImmunityBio, Inc. | Tax Payment(F) | 15,435 | $1.98 | $30,561 | Direct |
| Feb 22, 2025 | IBRX ImmunityBio, Inc. | Tax Payment(F) | 15,860 | $3.42 | $54,241 | Direct |
| Feb 22, 2025 | IBRX ImmunityBio, Inc. | Exercise(M) | 40,650 | - | - | Direct |
| Feb 10, 2025 | IBRX ImmunityBio, Inc. | Award(A) Restricted Stock Units | 246,710 | - | - | Direct |
| Feb 10, 2025 | IBRX ImmunityBio, Inc. | Award(A) Stock Option (right to buy) | 843,750 | - | - | Direct |
| Dec 31, 2024 | IBRX ImmunityBio, Inc. | Exercise(M) | 30,397 | - | $0 | Direct |
| Dec 31, 2024 | IBRX ImmunityBio, Inc. | Tax Payment(F) | 15,405 | $2.56 | $39,437 | Direct |
1-12 of 12 transactions
About Sachs David C.
Sachs David C. (SEC CIK 0001848899) files insider reports with the SEC as Chief Financial Officer of ImmunityBio, Inc. (IBRX).
Signal8 holds 6 ownership filings by Sachs David C., all Form 4s, filed between Jan 3, 2025 and Feb 24, 2026. Those filings report 12 transactions, from Dec 31, 2024 to Feb 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sachs David C.'s filings is in SAN DIEGO, CA.
Recent filings by Sachs David C.
- Feb 22, 2026: Tax withholding of IBRX shares (Form 4, code F).
- Feb 22, 2026: Option exercise of IBRX shares (Form 4, code M).
- Feb 10, 2026: Option exercise of IBRX shares (Form 4, code M).
- Feb 10, 2026: Tax withholding of IBRX shares (Form 4, code F).
- Dec 31, 2025: Option exercise of IBRX shares (Form 4, code M).
Other insiders filing for ImmunityBio, Inc. (IBRX)
- Simon Barry J., Director
- Cohen Cheryl, Director
- Selecky Christobel, Director
- BLASZYK MICHAEL D, Director
- Wendel Bruce, Director
- MAXWELL LINDA, Director